A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting

NCT02330640 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

137

Enrollment

OTHER

Sponsor class

Conditions

Antiplatelet Therapy of Coronary Artery Bypass

Interventions

DRUG: ticagrelor
DRUG: clopidogrel
DRUG: asprin

Sponsor

Chinese Academy of Medical Sciences, Fuwai Hospital